Advertisement

In Vitro Studies on the Secretion of Human Prolactin and Growth Hormone

  • François Cesselin
  • Françoise Peillon
Part of the Biochemical Endocrinology book series (BIOEND)

Abstract

The mechanisms that regulate the secretion of human prolactin (PRL) and growth hormone (GH) are varied and complex. No attempt will be made in this chapter to review in detail their neuroendocrine control or the multiplicity of physiological stimuli and pharmacological agents that are involved in their regulation.

Keywords

Growth Hormone Pituitary Adenoma Growth Hormone Secretion Acromegalic Patient Growth Hormone Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, E. F., and Mashiter, K., 1978, Prolactin and growth hormone secretion by dispersed cell cultures of somatotrophic, lactotrophic and mixed pituitary adenomas, Abstract, International Symposium on pituitary microadenomas, Milan, October 1978.Google Scholar
  2. Batzdorf, U., Gold, V., Matthews, N., and Brown, J., 1971, Human growth hormone in cultures of human pituitary tumors, J. Neurosurg. 34: 741.PubMedCrossRefGoogle Scholar
  3. Beau villain, J. C., Tramu, G., Mazzucca, M., Christiaens, J. L., L’Hermite, M., Asfour, M., Fossati, P. and Linquette, M., 1976, Étude morphologique d’un adénomeà prolactine après traitement par la 2-bromo ergocryptine (CB-154), Ann. Endocrinol. (Paris) 31: 117.Google Scholar
  4. Belleville, F., Hartman, P., Paysant, P. and Nabet, P., 1973, Incorporation de la leucine marquée (leucine3H) dans les protéines sécrétées par les cellules hypophysaires en culture, C. R. Soc. Biol. 167: 305.Google Scholar
  5. Benker, G., Mortimer, C. H., Chait, A., Lowry, P. J., Besser, G. M., Coy, D. H., Kastin, A., and Schally, A. V., 1975, Heterogeneity of human growth hormone in plasma and urine: Influence of growth hormone release inhibiting hormone, Acta Endocrinol. (Copenhagen) Suppl. 193, Abstract No. 72.Google Scholar
  6. Besser, G. N., Mortimer, C. H., McNeilly, A. S., Thorner, M. O., Batistoni, G. A., Bloom, S. R., Kastrup, K. W., Hanssen, K. F., Hall, R., Coy, D. H., Kastin, A. J., and Schally, A. V., 1974, Long term infusion of growth hormone release inhibiting hormone in acromegaly: Effects on pituitary and pancreatic hormones, Br. Med. J. 4: 622.PubMedCrossRefGoogle Scholar
  7. Besses, G. S., Burrow, G. N., Spaulding, S. W. and Donabedian, R. K., 1975, Dopamine infusion acutely inhibits the TSH and prolactin response to TRH, J. Clin. Endocrinol. Metab. 41: 985.PubMedCrossRefGoogle Scholar
  8. Binoux, M., Donnadieu, M., and Gourmelen, M., 1976, Hétérogénéité moléculaire de l’hormone de croissance humaine (hGH) sécrétée par des adénomes hypophysaires somatotropes en culture, in: Neuroendocrinologie Colloque INSERM, pp. 207–213, INSERM, Paris.Google Scholar
  9. Birge, C. A., Jacobs, L. S., Hammer, C. T., and Daughaday, W. H., 1970, Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses, Endocrinology 86: 120.PubMedCrossRefGoogle Scholar
  10. Blackard, W. G., and Heidingsfelder, S. A., 1968, Adrenergic receptor control mechanism for growth hormone secretion, J. Clin. Invest. 47: 1407.PubMedCrossRefGoogle Scholar
  11. Borgeat, P., Labrie, F., Drouin, J., Belanger, A., Immer, I., Sestanj, K., Nelson, V., Götz, M., Schally, A. V., Coy, D. H., and Coy, E. J., 1974, Inhibition of adenosine-3′,5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone, Biochem. Biophys. Res. Commun. 56: 1052.PubMedCrossRefGoogle Scholar
  12. Bowers, C. Y., Friesen, H., Guyda, H. J., and Folkers, K., 1971, Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide, Biochem. Biophys. Res. Commun. 45: 1033.PubMedCrossRefGoogle Scholar
  13. Boyd, A. E., Lebovitz, H. E., and Pfeifer, J. B., 1970, Stimulation of human-growth-hormone secretion by L-dopa, N. Engl. J. Med. 283: 1425.PubMedCrossRefGoogle Scholar
  14. Brauman, J., Brauman, H., and Pasteels, J. L., 1964, Immunoassay of growth hormone in cultures of human hypophysis by the method of complement fixation: Comparison of the growth hormone secretion and the prolactin activity, Nature (London) 202: 1116.CrossRefGoogle Scholar
  15. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R., 1973, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science 179: 77.PubMedCrossRefGoogle Scholar
  16. Bridson, W. E., and Köhler, P. O., 1970, Cortisol stimulation of growth hormone production by human pituitary tissue in culture, J. Clin. Endocrinol. Metab. 30: 538.PubMedCrossRefGoogle Scholar
  17. Brown, G. M., Seeman, P., and Lee, T., 1976, Dopamine/neuroleptic receptors in basal hypothalamus and pituitary, Endocrinology 99: 1407.PubMedCrossRefGoogle Scholar
  18. Brunet, N., Gourdji, D., Tixier-Vidal, A., Pradelles, P., Morgat, J. L., and Fromageot, P., 1974, Chemical evidence for associated TRF with subcellular fractions after incubation of intact rat prolactin cells (GH3) with3H-labelled TRF, FEBS Lett. 38: 129.CrossRefGoogle Scholar
  19. Burrow, G. N., May, P. B., Spaulding, S. W., and Donabedian, R. K., 1977, TRH and dopamine interactions affecting pituitary hormone secretion, J. Clin. Endocrinol. Metab. 45: 65.PubMedCrossRefGoogle Scholar
  20. Calabro, M. A., and MacLeod, R. M., 1978, Binding of dopamine to bovine anterior pituitary gland membranes, Neuroendocrinology 25: 32.PubMedCrossRefGoogle Scholar
  21. Camanni, F., Massara, F., Belforte, L., and Molinatti, G. M., 1975a, Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2 Br-α-ergocryptine, J. Clin. Endocrinoi. Metab. 40: 363.CrossRefGoogle Scholar
  22. Camanni, F., Massara, F., Fassio, V., Molinatti, G. M., and Müller, E. E., 1975b, Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects, Neuroendocrinology 19: 227.PubMedCrossRefGoogle Scholar
  23. Camanni, F., Massara, F., Belforte, L., Rosatello, A. and Molinatti, G. M., 1977, Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects, J. Clin. Endocrinoi. Metab. 44: 465.CrossRefGoogle Scholar
  24. Carlson, H. E., Mariz, I. K., and Daughaday, W. H., 1974, Thyrotropin-releasing hormone stimulation and somatostatin inhibition of growth hormone secretion from perfused rat adenohypophyses, Endocrinology 94: 1709.PubMedCrossRefGoogle Scholar
  25. Caron, M. G., Beaulieu, M., Raymond, V., Gagné, B., Drouin, J., Lefkowitz, R. J., and Labrie, F., 1978, Dopaminergic receptors in the anterior pituitary gland: Correlation of3H dihydroergocryptine binding with the dopaminergic control of prolactin release, J. Biol. Chem. 253: 2244.PubMedGoogle Scholar
  26. Carr, D., Gomez-Pän, A., Weightman, D. R., Roy, V. C. M., Hall, R., Besser, G. M., Thorner, M. O., McNeüly, A. S., Schally, A. V., Kastin, A. J., and Coy, D. H., 1975, Growth hormone release inhibiting hormone: Actions on thyrotrophin and prolactin secretion after thyrotrophin releasing hormone, Br. Med. J. 3: 67.PubMedCrossRefGoogle Scholar
  27. Catania, A., Cantalamessa, L., and Reschini, E., 1976, Plasma prolactin response to luteinizing hormone releasing hormone in acromegalic patients, J. Clin. Endocrinoi. Metab. 43: 689.CrossRefGoogle Scholar
  28. Chiodini, P. G., Liuzzi, A., Botalla, L., Cremascoli, G., and Silvestrini, F., 1974, Inhibitory effect of dopaminergic stimulation on GH release in acromegaly, J. Clin. Endocrinoi. Metab. 38: 200.CrossRefGoogle Scholar
  29. Convey, E. M., Tucker, H. A., Smith, V. G., and Zolman, J., 1973, Bovine prolactin, growth hormone, thyroxine and corticoid response to thyrotropin-releasing hormone, Endocrinology 92: 471.PubMedCrossRefGoogle Scholar
  30. Copinschi, G., Virasoro, E., Vanhaelst, L., Leckercq, R., Golstein, J., and L’Hermite, M., 1974, Specific inhibition by somatostatin of growth hormone release after hypoglycaemia in normal man, Clin. Endocrinoi. (Oxford) 3: 441.CrossRefGoogle Scholar
  31. Cronin, M. J., Roberts, J. M., and Weiner, R. I., 1978, Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep, Endocrinology 103: 302.PubMedCrossRefGoogle Scholar
  32. Cryer, P. E., and Daughaday, W. H., 1977, Adrenergic modulation of growth hormone secretion in acromegaly: Alpha-and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppression, J. Clin. Endocrinoi. Metab. 44: 977.CrossRefGoogle Scholar
  33. Czernichow, P., Dauzet, M. C., Broyer, M., and Rappaport, R., 1976, Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure, J. Clin. Endocrinoi. Metab. 43: 630.CrossRefGoogle Scholar
  34. Dannies, P. S., Gautvik, K. M., and Tashjian, A. H., 1976, A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture, Endocrinology 98: 1147.PubMedCrossRefGoogle Scholar
  35. De Camilli, P., Tagliabue, L., Päracchi, A., Faglia, G., Beck-Peccoz, P., and Giovanelli, M., 1978a, In vitro study on the release of GH by fragments of GH producing human pituitary adenomas: Effect of TRH and DBcAMP, in: Treatment of Pituitary Adenomas (R. Fahlbusch and K. V. Werder, eds.), pp. 172–179, Georg Thieme, Stuttgart.Google Scholar
  36. De Camilli, P., Spada, A., Peck-Peccoz, P., Moriando, P., Giovanelli, M., and Faglia, G., 1978b, Presence of a dopamine sensitive adenylate-cyclase in functioning human pituitary microadenomas, Abstract, International Symposium on Pituitary Microad-enomas, Milan, October 1978.Google Scholar
  37. Del Pozo, E., Brun del Re, R., Varga, L., and Friesen, H., 1972, The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine), J. Clin. Endocrinol. Metab. 35: 768.PubMedCrossRefGoogle Scholar
  38. Del Pozo, E., Friesen, H., and Burmeister, P., 1973, Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB-154): A preliminary report, Schweiz. Med. Wochenschr. 103: 847.PubMedGoogle Scholar
  39. Deuben, R., and Meites, J., 1963, In vitro stimulation of growth hormone release from rat anterior pituitary by extracts of rat hypothalamus, Fed. Proc. Fed. Am. Soc. Exp. Biol. 22: 571.Google Scholar
  40. Dieffenbach, W. P., Carmel, P. W., Frantz, A. G., and Ferin, M., 1976, Suppression of prolactin secretion by L-dopa in stalk-sectioned rhesus monkeys, J. Clin. Endocrinol. Metab. 43: 638.CrossRefGoogle Scholar
  41. Eddy, R. L., Jones, A. L., Chakmakjan, Z. H., and Silvertone, M. C., 1971, Effect of levodopa (L-dopa) on human hypophyseal trophic hormone release, J. Clin. Endocrinol. Metab. 33: 709.PubMedCrossRefGoogle Scholar
  42. Enjalbert, A., Ruberg, B., and Kordon, C., 1978, Neuroendocrine control of prolactin secretion, in: Progress in Prolactin Physiology and Pathology (C. Robyn and M. Harter, eds.), pp. 83–94, Elsevier/North-Holland, Amsterdam and New York.Google Scholar
  43. Faglia, G., Beck-Peccoz, P., Ferrari, C., Travaglini, P., Ambrosi, B., and Spada, A., 1973a, Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly, J. Clin. Endocrinol. Metab. 36: 1259.PubMedCrossRefGoogle Scholar
  44. Faglia, G., Beck-Peccoz, P., Travaglini, P., Paracchi, A., Spada, A., and Lewin, A., 1973b, Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly, J. Clin. Endocrinol. Metab. 37: 336.Google Scholar
  45. Farquhar, M. G., Skutelsky, E. H., and Hopkins, C. R., 1975, Structure and function of the anterior pituitary and dispersed pituitary cells: In vitro studies, in: The Anterior Pituitary Gland (A. Tixier-Vidal and M. G. Farquhar, eds.), Vol. 7, pp. 82–135, Academic Press, New York.Google Scholar
  46. Flückiger, E., Marko, M., Doepfner, W., and Niederer, W., 1976, Effects of ergot alkaloids on the hypothalamic-pituitary axis, Postgrad. Med. J. 52(Suppl. I):57.Google Scholar
  47. Franchimont, P., and Burger, H., 1975, Human Growth Hormone and Gonadotrophins in Health and Disease, North-Holland, Amsterdam; Oxford/Elsevier, New York.Google Scholar
  48. Friesen, H., Guyda, H., and Hardy, J., 1970, Biosynthesis of human growth hormone and prolactin, J. Clin. Endocrinol. Metab. 31: 611.PubMedCrossRefGoogle Scholar
  49. Friesen, H., Webster, B. R., Hwang, P., Guyda, H., Munro, R. E., and Read, L., 1972, Prolactin synthesis and secretion in a patient with the Forbes Albright syndrome, J. Clin. Endocrinol. Metab. 34: 192.PubMedCrossRefGoogle Scholar
  50. Frohman, L. A., and Stachura, M. E., 1973, Evidence for possible precursors in the synthesis of growth hormone by rat and human fetal anterior pituitary in vitro, Mt. Sinai J. Med. N.Y. 40: 414.Google Scholar
  51. Gailani, S. D., Nussbaum, A., McDougall, W. J., and McLimans, W. F., 1970, Studies on hormone production by human fetal pituitary cell cultures, Proc. Soc. Exp. Biol. Med. 134: 27.PubMedGoogle Scholar
  52. Gala, R. R., 1971, Prolactin production by the human anterior pituitary cultured in vitro, J. Endocrinol. 50: 637.PubMedCrossRefGoogle Scholar
  53. Gala, R. R., Subramanian, M. G., Peters, J. A., and Jacques, S.Jr., 1976, The influence of somatostatin on drug-induced prolactin release in the monkey, Experientia 32: 941.PubMedCrossRefGoogle Scholar
  54. Giustina, G., Reschini, E., Peracchi, M., Cantalamessa, L., Cavagnini, F., Pinto, M., and Bulgheroni, P., 1974, Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone-induced growth hormone release in acromegaly, J. Clin. EndocrinoL Metab. 38: 906.PubMedCrossRefGoogle Scholar
  55. Glick, S. M., Roth, J., Yalow, R. S., and Berson, S. A., 1965, The regulation of growth hormone secretion, Recent Prog. Horm. Res. 21: 241.PubMedGoogle Scholar
  56. Gonzales-Barcena, D., Kastin, A. J., Schalch, D. S., Torres-Zamora, M., Peres-Pasten, E., Kato, A., and Schally, A. V., 1973, Response to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men, J. Clin. Endocrinol. Metab. 36: 117.CrossRefGoogle Scholar
  57. Goodyer, C. G., Hall, C. St.G., Guyda, H., Robert, F., and Giroud, C. J. P., 1977, Human fetal pituitary in culture: Hormone secretion and response to somatostatin, luteinizing hormone releasing factor, thyrotropin releasing factor and dibutyryl cyclic AMP, J. Clin. EndocrinoL Metab. 45: 73.PubMedCrossRefGoogle Scholar
  58. Gourdji, D., Morin, A., and Tixier-Vidal, A., 1973a, Study on the control of prolactin secretion by two continuous lines of rat pituitary prolactin cells, in: Human Prolactin (J. L. Pasteels and C. Robyn, eds.), pp. 163–166, Excerpta Medica, Amsterdam.Google Scholar
  59. Gourdji, D., Tixier-Vidal, A., Morin, A., Pradelles, P., Morgat, J. L., and Fromageot, P., 1973b, Binding of tritiated thyrotropin releasing factor to a prolactin secreting clonal cell line (GH3), Exp. Cell Res. 82: 39.PubMedCrossRefGoogle Scholar
  60. Gräf, K. J., Horowski, R., and El Etreby, M. F., 1977, Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary glands in rats, Acta Endocrinol. (Copenhagen) 85: 267.Google Scholar
  61. Grant, N. H., Sarantakis, D., and Yardley, J. P., 1974, Action of growth hormone release inhibitory hormone on prolactin release in rat pituitary cell cultures, J. Endocrinol. 61: 163.PubMedCrossRefGoogle Scholar
  62. Groom, G. V., Groom, M. A., Cooke, I. B., and Boyns, A. R., 1971, The secretion of immuno-reactive luteinizing-hormone and follicle-stimulating hormone by the human foetal pituitary in organ culture, J. Endocrinol. 49: 335.PubMedCrossRefGoogle Scholar
  63. Guibout, M., Jaquet, P., Lucas, C., Hassoun, J., Charpin, C. and Grisoli, F., 1978, In vitro and in vivo effects of TRH and bromocriptine on GH-secreting adenomas, Abstract, International Symposium on Pituitary Microadenomas, Milan, October 1978.Google Scholar
  64. Guyda, H. J., 1975, Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations, J. Clin. EndocrinoL Metab. 41: 953.PubMedCrossRefGoogle Scholar
  65. Guyda, H., Robert, F., Colle, E., and Hardy, J. 1973, Histologic, ultrastructural and hormonal characterization of a pituitary tumor secreting both hGH and prolactin, J. Clin. EndocrinoL Metab. 36: 531.Google Scholar
  66. Hagen, T. C., Guansing, A. R., and Sill, A. J., 1976, Preliminary evidence for a human prolactin releasing factor, Neuroendocrinology 21: 255.PubMedCrossRefGoogle Scholar
  67. Hall, R., Besser, G. M., Schally, A. V., Coy, D. H., Evered, D., Goldie, D. J., Kastin, A. J., MacNeilly, A. S., Mortimer, C. H., Phenekos, C., Tunbridge, W. M. G., and Weightman, D., 1973, Action of growth hormone release inhibitory hormone in healthy men in acromegaly, Lancet 2: 581.PubMedCrossRefGoogle Scholar
  68. Hansen, A. P., 1971, The effect of adrenergic receptor blockade on the exercise induced serum growth hormone rise in normal and juvenile subjects, J. Clin. Endocrinol. Metab. 33: 807.PubMedCrossRefGoogle Scholar
  69. Hansen, A. P., Orkson, H., Seyer-Hansen, K., and Lundbaek, K., 1973, Some actions of growth hormone release inhibiting factor, Br. Med. J. 3: 523.PubMedCrossRefGoogle Scholar
  70. Heidingsfelder, S. A., and Blackard, W. G., 1968, Adrenergic control mechanism for vasopressin induced plasma growth hormone response, Metabolism 17: 1019.PubMedCrossRefGoogle Scholar
  71. Hill-Samli, M., and MacLeod, R. M., 1974, Interaction of thyrotropin-releasing hormone and dopamine on the release of prolactin from the rat anterior pituitary in vitro, Endocrinology 95: 1189.PubMedCrossRefGoogle Scholar
  72. Hill-Samli, M., and MacLeod, R. M., 1975, TRH blockade of the ergocryptine and apomorphine inhibition of prolactin release in vitro, Proc. Soc. Exp. Biol. Med. 149: 511.PubMedGoogle Scholar
  73. Hinckle, P. M., and Tashjian, A. H., 1973, Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture, J. Biol. Chem. 248: 6180.Google Scholar
  74. Hwang, P., Friesen, H., Hardy, J., and Wilansky, D., 1971, Biosynthesis of human growth hormone and prolactin by normal pituitary glands and pituitary adenomas, J. Clin. Endocrinol. Metab. 33: 1.PubMedCrossRefGoogle Scholar
  75. Imura, H., Kato, Y., Ikeda, M., Morimoto, M. and Yawata, M., 1971, Effect of adrenergic-blocking or stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man, J. Clin. Invest. 50: 1069.PubMedCrossRefGoogle Scholar
  76. Irie, M., and Tsushima, T., 1972, Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism, J. Clin. Endocrinol. Metab. 35: 97.PubMedCrossRefGoogle Scholar
  77. Jacobs, L. S., Snyder, P. J., Utiger, R. D., Wilber, J. F., and Daughaday, W. H., 1971, Increased serum prolactin after administration of synthetic thyrotropin-releasing hormone (TRH) in man, J. Clin. Endocrinol. Metab. 33: 996.PubMedCrossRefGoogle Scholar
  78. Jimenez, A. E., Voogt, J. L., and Carr, L. A., 1978, L-3,4-Dihydroxyphenylalanine (L-dopa) as an inhibitor of prolactin release, Endocrinology 102: 166.PubMedCrossRefGoogle Scholar
  79. Kamberi, I. A., Mical, R. S., and Porter, J. C., 1971, Effect of anterior pituitary perfusion and intraventricular injections of catecholamines on prolactin release, Endocrinology 88: 1012.PubMedCrossRefGoogle Scholar
  80. Karlberg, B., Almqvist, S., and Werner, S., 1971, Effects of synthetic pyroglutamyl-histidyl-prolinamide on serum levels of thyrotrophin, cortisol, growth hormone, insulin and PBI in normal subjects and patients with pituitary and thyroid disorders, Acta Endocrinol. (Copenhagen) 67: 288.Google Scholar
  81. Kleinberg, D. L., Noel, G. L., and Frantz, A. G., 1971, Chlorpromazine stimulation and L-dopa suppression of plasma prolactin in man, J. Clin. Endocrinol. Metab. 33: 873.CrossRefGoogle Scholar
  82. Knazek, R. A., and Skyler, J. S., 1976, Secretion of human prolactin in vitro, Proc. Soc. Exp. Biol. Med. 151: 561.PubMedGoogle Scholar
  83. Koch, Y., Lu, K. H., and Meites, J., 1970, Biphasic effects of catecholamines on pituitary prolactin release in vitro, Endocrinology 87: 673.PubMedCrossRefGoogle Scholar
  84. Kohler, P. O., Bridson, W. E., Rayford, P. L., and Köhler, S. E., 1969, Hormone production by human pituitary adenomas in culture, Metabolism 18: 782.PubMedCrossRefGoogle Scholar
  85. Kohler, P. O., Bridson, W. E., and Chrambach, A., 1971, Human growth hormone produced in tissue culture: Characterization by polyacrylamide gel electrophoresis, J. Clin. Endocrinol. Metab. 32: 70.PubMedCrossRefGoogle Scholar
  86. Kovacs, K., Horwath, E., and Ezrin, C., 1977, Pituitary adenomas, in: Pathology Annual (S. C. Sommers and P. P. Rosen, eds.) Vol. 12, pp. 341–382, Appleton-Century-Crofts, New York.Google Scholar
  87. Krieger, D. T., and Glick, S. M., 1974, Sleep EEG stages and plasma growth hormone concentration in states of endogenous hypercortisolemia or ACTH elevation, J. Clin. Endocrinol. Metab. 39: 986.PubMedCrossRefGoogle Scholar
  88. LaBella, F., and Vivian, S. R., 1971, Effect of synthetic TRF on hormone release from bovine anterior pituitary in vitro, Endocrinology 88: 787.PubMedCrossRefGoogle Scholar
  89. Labrie, F., Pelletier, G., Borgeat, P., Drouin, J., Ferland, L., and Belanger, A., 1976, Mode of action of hypothalamic regulatory hormones in the adenohypophysis, in: Frontiers in Neuroendocrinology, Vol. IV (L. Martini and W. F. Ganong, eds.), pp. 63–93, Raven Press, New York.Google Scholar
  90. Lal, S., De La Vega, C. E., Sourkes, T. L., and Friesen, H. G., 1972, Effect of apomorphine on human growth hormone secretion, Lancet 2: 601.Google Scholar
  91. Langer, G., and Matussek, M., 1977, Dextro-and L-amphetamine are equipotent in releasing human growth hormone, Psychoneuroendocrinology 2: 379.PubMedCrossRefGoogle Scholar
  92. Leblanc, H., Lachelin, G. C. L., Abu-Fadil, S., and Yen, S. C., 1976. Effects of dopamine infusion on pituitary hormone secretion in humans, J. Clin. Endocrinol. Metab. 43: 668.PubMedCrossRefGoogle Scholar
  93. Leebaw, W. F., Lee, L. A., and Woolf, P. D., 1978, Dopamine affects basal and augmented pituitary hormone secretion, J. Clin. Endocrinol. Metab. 47: 480.PubMedCrossRefGoogle Scholar
  94. Liuzzi, A., Chiodini, P. G., Botalla, L., Cremascoli, G., Müller, E. E., and Silvestrini, F., 1974a, Decreased plasma growth hormone (GH) levels in acromegalics following CB-154 (2-Brα-ergocryptine) administration, J. Clin. Endocrinol. Metab. 38: 910.PubMedCrossRefGoogle Scholar
  95. Liuzzi, A., Chiodini, P. G., Botalla, L., Silvestrini, F., and Müller, E. E., 1974b, Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: Homogeneity in the two responses, J. Clin. Endocrinol. Metab. 39: 871.PubMedCrossRefGoogle Scholar
  96. Lu, K. H., Shaar, C. J., Kortright, K. H., and Meites, J., 1972, Effects of synthetic TRH on in vitro and in vivo prolactin release in the rat, Endocrinology 91: 1540.PubMedCrossRefGoogle Scholar
  97. Machlin, L. J., Jacobs, L. S., Cirulis, N., Kimes, R., and Miller, R., 1974, An assay for growth hormone and prolactin-releasing activities using bovine pituitary cell culture system, Endocrinology 96: 1350.CrossRefGoogle Scholar
  98. MacLeod, R. M., 1976, Regulation of prolactin secretion, in: Frontiers in Neuroendocrinology, Vol. 4, (L Martini and W. F. Ganong, eds.), pp. 169–194, Raven Press, New York.Google Scholar
  99. MacLeod, R. M., and Lehmeyer, J. E., 1972, Regulation of the synthesis and release of prolactin, in: Lactogenic Hormones (G. E. W. Wolstenholme and J. Knight, eds.), pp. 53–82, Churchill-Livingstone, London.Google Scholar
  100. MacLeod, R. M., and Lehmeyer, J. E., 1974, Studies on the mechanism of dopamine mediated inhibition of prolactin secretion, Endocrinology 94: 1077.PubMedCrossRefGoogle Scholar
  101. MacLeod, R. M., Fontham, E. H., and Lehmeyer, J. E., 1970, Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines, Neuroendocrinology 6: 283.PubMedCrossRefGoogle Scholar
  102. Malarkey, W. B., and Daughaday, W. H., 1972, The influence of levodopa and adrenergic blockade on growth hormone and prolactine secretion in the MStTW15 tumor bearing rat, Endocrinology 91: 1314.PubMedCrossRefGoogle Scholar
  103. Malarkey, W. B., and Pankratz, K., 1974, Evidence for prolactin releasing activity in human plasma not associated with TSH release, Clin. Res. 22: 600A.Google Scholar
  104. Martin, J. B., 1973, Neural regulation of growth hormone secretion: Medical progress report, N. Engl. J. Med. 288: 1384.PubMedCrossRefGoogle Scholar
  105. Martin, J. B., Reichlin, S., and Brown, G. M., 1977a, Regulation of prolactin secretion and its disorders, in: Clinical Neuroendocrinology, Contemporary Neurology Series, pp. 129–145, F. A. Davis, Philadelphia.Google Scholar
  106. Martin, J. B., Reichlin, S., and Brown, G. M., 1977b, Regulation of growth hormone secretion and its disorders, in: Clinical Neuroendocrinology, Contemporary Neurology Series, pp. 147–178, F. A. Davis, Philadelphia.Google Scholar
  107. Mashiter, K., Adams, E., Beard, M., and Holley, A., 1977, Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture, Lancet 2: 197.PubMedCrossRefGoogle Scholar
  108. Matsukura, S., Kakita, T., Hirata, Y., Yoshimi, H., Fukase, M., Iwasaki, Y., Kato, Y., and Imura, H., 1977, Adenylate cyclase of GH and ACTH producing tumors of human: Activation by non specific hormones and other bioactive substances, J. Clin. Endocrinol. Metab. 44: 392.PubMedCrossRefGoogle Scholar
  109. Meites, J., Kahn, R. H., and Nicoll, C. S., 1961, Prolactin production by rat pituitary in vitro, Proc. Soc. Exp. Biol. Med. 108: 440.Google Scholar
  110. Morin, A., Tixier-Vidal, A., Gourdji, D., Kerdelhué, B., and Grouselle, D., 1975, Effect of thyreotrope-releasing hormone (TRH) on prolactin turnover in culture, Mol. Cell. Endocrinol. 3: 351.PubMedCrossRefGoogle Scholar
  111. Mueller, G. P., Chen, H. J., and Meites, J., 1973, In vivo stimulation of prolactin release in the rat by synthetic TRH, Proc. Soc. Exp. Biol. Med. 144: 613.PubMedGoogle Scholar
  112. Müller, E. E., 1974, Growth hormone and the regulation of metabolism, in: Endocrine Physiology (S. M. McCann, ed.), p. 141, Butterworths, London.Google Scholar
  113. Müller, E. E., Liuzzi, A., Cocchi, D., Panerai, A. E., Oppizzi, G., and Chiodini, P. G., 1977, The role of dopaminergic receptors in the regulation of growth hormone secretion, in: Symposium on Non-Striatal Dopaminergic Neurons (E. Costa, ed.), p. 127, Raven Press, New York.Google Scholar
  114. Müller, E. E., Chiodini, P. G., Cocchi, D., Panerai, A. E., Oppizi, G., Colussi, G., Locatelli, V., and Liuzzi, A., 1978, Neurotransmitter control of growth hormone secretion, in: Treatment of Pituitary Adenomas (R. Fahlbusch and K. Von Werder, eds.), pp. 360–377, Georg Thieme, Stuttgart.Google Scholar
  115. Nagasawa, H., Yanai, R., and Flückiger, E., 1973, Counteraction by 2-Br-α-ergocryptine of pituitary prolactin release promoted by dibutyryl-adenosine-3′,5′-monophosphate in rats, in: Human Prolactin (J. L. Pasteels and C. Robyn, eds.), pp. 313–315; Excerpta Medica, Amsterdam.Google Scholar
  116. Noel, G. L., Suh, H. K., and Frantz, A. G., 1973, L-dopa suppression of TRH-stimulated prolactin release in man, J. Clin. Endocrinol. Metab. 36: 1255.PubMedCrossRefGoogle Scholar
  117. Noel, G. L., Dimond, R. C., Wartofsky, L., Earll, J. M., and Frantz, A. G., 1974, Studies of prolactin and TSH secretion by continuous infusion of small amounts of thyrotropin-releasing hormone (TRH), J. Clin. Endocrinol. Metab. 39: 6.PubMedCrossRefGoogle Scholar
  118. Olendorf, W. H., 1971, Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection, Am. J. Physiol. 221: 1629.Google Scholar
  119. Olivier, L., Vila-Porcile, E., Racadot, O., Peilion, F., and Racadot, J., 1975, Ultrastructure of pituitary tumor cells: A critical study, in: The Anterior Pituitary (A. Tixier-Vidal and M. G. Farquhar, eds.), pp. 231–276, Academic Press, New York.Google Scholar
  120. Ormston, B. J., Kilbron, J. R., Garry, R., Amos, J., and Hall, R., 1971, Further observations on the effect of synthetic thyrotropin-releasing hormone in man, Br. Med. J. 2: 199.PubMedCrossRefGoogle Scholar
  121. Panerai, A. E., Gil-Ad, I., Cocchi, D., Locatelli, V., Rossi, G. L., and Müller, E. E., 1977, Thyrotrophin releasing hormone-induced growth hormone and prolactin release: Physiological studies in intact rats and in hypophysectomized rats bearing an ectopic pituitary gland, J. Endocrinol. 72: 301.PubMedCrossRefGoogle Scholar
  122. Parker, D. C., Rossman, L. G., Siler, T. M., Rivier, J., Yen, S. S. C., and Guillemin, R., 1974, Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin, J. Clin. Endocrinol. Metab. 38: 496.PubMedCrossRefGoogle Scholar
  123. Parra, A., Schultz, R. B., Foley, T. P.,Jr., and Blizzard, R. M., 1970, Influence of epinephrine-propranolol infusions in growth hormone release in normal and hypopi-tuitary subjects, J. Clin. Endocrinol. Metab. 30: 134.PubMedCrossRefGoogle Scholar
  124. Pasteels, J. L., 1961a, Sécrétion de prolactine par l’hypophyse en culture de tissus, C. R. Acad. Sci. 253: 2140.Google Scholar
  125. Pasteels, J. L., 1961b, Premiers résultats de culture combinée in vitro d’hypophyse et d’hypothalamus, dans le but d’en apprécier la sécrétion de prolactine, C. R. Acad. Sci. 253: 3074.Google Scholar
  126. Pasteeis, J. L., 1962, Elaboration par l’hypophyse humaine en culture de tissus d’une substance stimulant le jabot de pigeon, C. R. Acad. Sci. 254: 4083.Google Scholar
  127. Pasteeis, J. L., 1969, Nouvelles recherches sur la structure et le comportement des cellules hypophysaires in vitro, Mem. Acad. R. Med. Belg. 7: 1.Google Scholar
  128. Pasteels, J. L., Brauman, H., and Brauman, J., 1963, Étude comparée de la sécrétion d’hormone somatotrope par l’hypophyse humaine in vitro et de son activité lactogénique, C. R. Acad. Sci. 256: 2031.Google Scholar
  129. Pasteels, J. L., Danguy, A., Frérotte, M., and Ectors, F., 1971, Inhibition de la sécrétion de prolactine par l’ergocornine et la 2-Br-α-ergocryptine: Action directe sur l’hypophyse en culture, Ann. Endocrinol. (Paris) 32: 188.Google Scholar
  130. Pasteels, J. L., Gausset, P., Danguy, A., Ectors, F., Nicoll, C. S., and Varavudhi, P., 1972, Morphology of the lactotropes and somatotropes of man and rhesus monkeys, J. Clin. Endocrinol. Metab. 34: 959.PubMedCrossRefGoogle Scholar
  131. Paulin, G., Li, J., Begeot, M., and Dubois, P. M., 1976, La somatostatine et la fonction somatotrope antehypophysaire chez le foetus humain, in: Neuroendocrinologie, Colloque INSERM, pp. 275–2251, INSERM, Paris.Google Scholar
  132. Pecile, A., and Müller, E. E. (eds.), 1976, Growth Hormone and Related Peptides, Proceedings of the IIIrd International Symposium, Excerpta Medica, Amsterdam.Google Scholar
  133. Peillon, F. Gourmelin, M., Brandi, A. M., and Donnadieu, M., 1972, Adénomes somatotropes humains en culture organotypique: Ultrastructure et sécrétion étudiée à l’aide de leucine tritiée, C. R. Acad. Sci. 275: 2251.Google Scholar
  134. Peillon, F., Gourmelin, M., Donnadieu, M., Brandi, A. M., Sevaux, D., and Pham Huu Trung, M. T., 1975, Organ culture of human somatotrophic pituitary adenomas: Ultrastructure and growth hormone production, Acta Endocrinol. (Copenhagen) 79: 217.Google Scholar
  135. Peillon, F., Garnier, P. E., Chaussain, J. L., Brandi, A. M., and Rivaille, P., 1976a, Growth hormone secretion by human somatotrophic adenomas in vitro: Effect of somatostatin, in: Hypothalamus and Endocrine Functions (F. Labrie, J. Meites, and G. Pelletier, eds.), Current Topics in Molecular Endocrinology, Vol. 3, abstract 36, p. 496, Springer Science+Business Media New York .Google Scholar
  136. Peillon, F., Garnier, P. E., Brandi, A. M., Rivaille, P., Cesselin, F., and Chaussain, J. L., 1976b, Effet in vitro de la somatostatine sur les adénomes somatotropes humains: Étude ultrastructurale et hormonale, in: Neuroendocrinologie, Colloque INSERM, pp. 215–224, INSERM, Paris.Google Scholar
  137. Peillon, F., Cesselin, F., Zygelman, N., Brandi, A. M., and Mauborgne, A., 1978a, Effet in vitro de la L-dopa, de la dopamine et du CB 154 sur la sécrétion de prolactine par les adénomes somatotropes humains, Ann. Endocrinol. (Paris) 39: 255.Google Scholar
  138. Peillon, F., Cesselin, F., Garnier, P. E., Brandi, A. M., Donnadieu, M., L’Hermitte, M., and Dubois, P. M., 1978b, Prolactin secretion and synthesis in short and long-term organ culture of pituitary tumours from acromegalic patients, Acta Endocrinol. (Copenhagen) 87: 701.Google Scholar
  139. Quadri, S. K., and Meites, J., 1973, Effect of ergocornin and CG 603 on blood-prolactin and GH in rats bearing a pituitary tumor (37128), Proc. Soc. Exp. Bio. Med. 142: 837.Google Scholar
  140. Quijada, M., Illner, P., Krulich, L., and McCann, S. M., 1973, The effect of catecholamines on hormone release from anterior pituitaries and ventral hypothalami incubated in vitro, Neuroendocrinology 13: 151.PubMedCrossRefGoogle Scholar
  141. Rabinowitz, D., Merimee, T. J., Burgess, J. A., and Riggs, L., 1966, Growth hormone and insulin release after arginine: Indifference to hyperglycemia and epinephrine, J. Clin. Endocrinol. Metab. 26: 1170.PubMedCrossRefGoogle Scholar
  142. Racadot, J., Vila-Porcile, E., Olivier, L., and Peillon, F., 1975, Electron microscopy of pituitary tumours, in: Progress of Neurological Surgery (H. Krayenbühl, ed.), pp. 95–141, S. Karger, Basel.Google Scholar
  143. Rubin, A. L., Levin, S. R., Bernstein, R. I., Tyrrell, J. B., Noacco, C., and Forsham, P. H., 1973, Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly, J. Clin. Endocrinol. Metab. 37: 160.PubMedCrossRefGoogle Scholar
  144. Rutlin, E., Hang, E., and Torjesen, P. A., 1977, Serum thyrotrophin, prolactin and growth hormone response to TRH during oestrogen treatment, Acta Endocrinol. (Copenhagen) 84: 23.Google Scholar
  145. Sawano, S., Baba, Y., Kokubu, T., and Ishizuka, Y., 1974, Effect of synthetic growth hormone releasing inhibiting factor on the secretion of growth hormone and prolactin in rats, Endocrinol. Jpn. 21: 399.PubMedCrossRefGoogle Scholar
  146. Schalch, D. S., 1967, The influence of physical stress and exercise on growth hormone and insulin secretion in man, J. Lab. Clin. Med. 69: 256.PubMedGoogle Scholar
  147. Schally, A. V., Arimura, A., Bowers, C. Y., Wakabayashi, I., Kastin, A. J., Redding, T. W., Mittler, J. C., Nair, R. M. G., Rizzolato, P., and Segal, A. J., 1970, Purification of hypothalamic releasing hormones of human origin, J. Clin. Endocrinol. Metab. 31: 291.PubMedCrossRefGoogle Scholar
  148. Schams, D., and Reinhardt, V., 1973, Prolactin release in the bovine stimulated by synthetic TRH and inhibited by 2-Br-a-ergokryptine, Ada Endocrinol. Suppl. (Copenhagen) 177: 144.Google Scholar
  149. Shaar, C. J., and Clemens, J. A., 1974, The role of catecholamines in the release of anterior pituitary prolactin in vitro. Endocrinology 95: 1202.PubMedCrossRefGoogle Scholar
  150. Siler, T. M., Morgenstern, L. L., and Greenwood, F. C., 1972, The release of prolactin and other peptides hormones from human anterior tissue cultures, in: Lactogenic Hormones, Ciba Found. Symp. (G. E. W. Wolstenholme and J. Knight, eds.), pp. 207–217, Churchill-Livingstone, London.Google Scholar
  151. Siler, T. M., Vandenberg, G., Yen, S. S. C., Brazeau, P., Vale, W., and Guillemin, R., 1973, Inhibition of growth hormone release in humans by somatostatin, J. Clin. Endocrinol. Metab. 37: 632.PubMedCrossRefGoogle Scholar
  152. Siler-Khodr, T., Morgenstern, L. L., and Greewood, F. C., 1974, Hormone synthesis and release from human fetal adenohypophyses in vitro, J. Clin. Endocrinol. Metab. 39: 891.PubMedCrossRefGoogle Scholar
  153. Skyler, J. S., Rogol, A. D., Lovenberg, W., and Knazek, R. A., 1977, Characterization of growth hormone and prolactin produced by human pituitary in culture, Endocrinology 100: 283.PubMedCrossRefGoogle Scholar
  154. Smythe, G. A., 1977, The role of serotonin and dopamine in hypothalamic-pituitary function, Clin. Endocrinol. (Oxford) 7: 325.CrossRefGoogle Scholar
  155. Snyder, J., Hymer, W. C., and Wilfinger, W. W., 1978, Culture of human pituitary prolactin and growth hormone cells, Cell Tissue Res. 191: 379.PubMedCrossRefGoogle Scholar
  156. Steiner, A. L., Peake, G. T., Utiger, R. D., Karl, I. E., and Kipnis, D. M., 1970, Hypothalamic stimulation of growth hormone and thyrotropin release in vitro and pituitary 3′,5′-adenosine cyclic monophosphate, Endocrinology 86: 1354.PubMedCrossRefGoogle Scholar
  157. Strauch, G., Modigliani, E., and Bricaire, H., 1969, Growth hormone response to arginine in normal and hyperthyroid females under propranolol, J. Clin. Endocrinol. Metab. 29: 606.PubMedCrossRefGoogle Scholar
  158. Strauch, G., Pique, L., and Bricaire, H., 1970, Application de la méthode de séparation par le talc au dosage radioimmunologique de l’hormone somatotrope, Ann. Biol. Clin. (Paris) 28: 41.Google Scholar
  159. Takahara, J., Arimura, A., and Schally, A. V., 1974a, Suppression of prolactin release by a purified porcine PIF and catecholamines infused into a rat hypophyseal portal vessel, Endocrinology 95: 462.PubMedCrossRefGoogle Scholar
  160. Takahara, J., Arimura, A., and Schally, A. V., 1974b, Effect of catecholamines on the TRH-stimulated release of prolactin and growth hormone from sheep pituitaries in vitro, Endocrinology 95: 1490.PubMedCrossRefGoogle Scholar
  161. Takahara, J., Arimura, A., and Schally, A. V., 1974b, Stimulation of prolactin and growth hormone release by TRH infused into a hypophysial portal vessel, Proc Soc. Exp. Biol. Med. 146: 831.PubMedGoogle Scholar
  162. Talwaker, P. K., Ratner, A., and Meites, J., 1963, In vitro inhibition of pituitary prolactin synthesis and release by hypothalamic extracts, Am. J. Physiol. 205: 213.Google Scholar
  163. Tashjian, A. H., Barowsky, N. J., and Jensen, D. K., 1971, Thyrotropin-releasing hormone: Direct evidence for stimulation of prolactin production by pituitary cells in culture, Biochem. Biophys. Res. Commun. 43: 516.PubMedCrossRefGoogle Scholar
  164. Thompson, K. W., Vincent, M. M., Jensen, P. C., Price, R. T., and Shapiro, E., 1959, Production of hormones by human anterior pituitary cells in serial culture, Proc. Soc. Exp. Biol. Med. 102: 403.PubMedGoogle Scholar
  165. Thorner, M. O., Chait, A., Aitken, M., Benker, G., Bloom, S. M., Mortimer, G. H., Sanders, P., Stuart Mason, A., and Besser, G. M., 1975, Bromocriptine treatment of acromegaly, Br. Med. J. 1: 299.PubMedCrossRefGoogle Scholar
  166. Tixier-Vidal, A., 1975, Ultrastructure of anterior pituitary cells in culture, in: The Anterior Pituitary (A. Tixier-Vidal and M. G. Farquhar, eds.), Vol. 7, pp. 181–229, Academic Press, New York.Google Scholar
  167. Torjesen, P. A., Hang, E., and Sand, T., 1973, Effect of thyrotropin releasing hormone on serum levels of pituitary hormones in men and women, Acta Endocrinol. (Copenhagen) 73: 455.Google Scholar
  168. Udeschini, G., Cocchi, D., Panerai, A. E., Gil-Ad, I., Rossi, G. L., Chiodini, P. G., Liuzzi, A., and Müller, E. E., 1976, Stimulation of growth hormone release by thyrotropin-releasing hormone in hypophysectomized rat bearing an ectopic pituitary, Endocrinology 98: 807.PubMedCrossRefGoogle Scholar
  169. Vale, W., Blackwell, R., Grant, G., and Guillemin, R., 1973, TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro, Endocrinology 93: 26.PubMedCrossRefGoogle Scholar
  170. Vale, W., Rivier, C., Brazeau, P., and Guillemin, R., 1974, Effects of somatostatin on the secretion of thyrotropin and prolactin, Endocrinology 95: 968.PubMedCrossRefGoogle Scholar
  171. Verde, C., Oppizzi, G., Colussi, G., Cremascoli, G., Botalla, L., Müller, E. E., Silvestrini, F., Chiodini, P. G., and Liuzzi, A., 1976, Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in acromegalic patients, Clin. Endocrinol. (Oxford) 5: 419.CrossRefGoogle Scholar
  172. Woolf, P. D., Jacobs, L. S., Donofrio, R., Bureday, S. Z., and Schalch, D. S., 1974, Secondary hypopituitarism: Evidence of continuing regulation of hormone release, J. Clin. Endocrinol. Metab. 38: 71.PubMedCrossRefGoogle Scholar
  173. Yanai, R., and Nagasawa, 1974, Effect of 2-Br-α-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats, Horm. Res. 5: 1.PubMedCrossRefGoogle Scholar
  174. Yen, S. S. C., Siler, T. N., and de Vane, G. W., 1974, Effect of somatostatin in patients with acromegaly: Suppression of growth hormone, prolactin, insulin and glucose levels, N. Engl. J. Med. 290: 935.PubMedCrossRefGoogle Scholar
  175. Zimmerman, E. A., Defendini, R., and Frantz, A. G., 1974, Prolactin and growth hormone in patients with pituitary adenomas: A correlative study of hormone in tumor and plasma by immunoperoxidase technique and radioimmunoassay, J. Clin. Endocrinol. Metab. 38: 577.PubMedCrossRefGoogle Scholar
  176. Zor, U., Kaneko, T., Schneider, H. P., McCann, S. M., Lowe, I. P., Bloom, G., Borland, B., and Field, J. B., 1969, Stimulation of anterior pituitary adenyl cyclase activity and adenosine 3′:5′-cyclic phosphate by hypothalamic extract and prostaglandin E1, Proc. Natl. Acad. Sci. U.S.A. 63: 918.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • François Cesselin
    • 1
  • Françoise Peillon
    • 1
  1. 1.Service de Biochimie Médicale et Laboratoire d’Histologie-Embryologie (C.N.R.S. ERA 484)Faculté de Médecine Pitié-SalpêtrièreParis 13France

Personalised recommendations